CN102631436B - Medicament for treating encephalatrophy - Google Patents
Medicament for treating encephalatrophy Download PDFInfo
- Publication number
- CN102631436B CN102631436B CN 201210142857 CN201210142857A CN102631436B CN 102631436 B CN102631436 B CN 102631436B CN 201210142857 CN201210142857 CN 201210142857 CN 201210142857 A CN201210142857 A CN 201210142857A CN 102631436 B CN102631436 B CN 102631436B
- Authority
- CN
- China
- Prior art keywords
- parts
- medicament
- encephalatrophy
- treating
- organisms
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000003814 drug Substances 0.000 title claims abstract description 23
- 241001180876 Saposhnikovia Species 0.000 claims abstract description 3
- 208000024806 Brain atrophy Diseases 0.000 claims description 13
- 229940079593 drug Drugs 0.000 claims description 5
- 241000628997 Flos Species 0.000 claims description 4
- 241000545442 Radix Species 0.000 claims description 4
- 239000002316 fumigant Substances 0.000 claims description 4
- 230000017531 blood circulation Effects 0.000 abstract description 4
- 210000004204 blood vessel Anatomy 0.000 abstract description 3
- 230000002757 inflammatory effect Effects 0.000 abstract description 2
- 239000002207 metabolite Substances 0.000 abstract description 2
- 230000035699 permeability Effects 0.000 abstract description 2
- 230000008092 positive effect Effects 0.000 abstract description 2
- 230000000191 radiation effect Effects 0.000 abstract description 2
- 230000001737 promoting effect Effects 0.000 abstract 2
- 244000061520 Angelica archangelica Species 0.000 abstract 1
- 241000213006 Angelica dahurica Species 0.000 abstract 1
- 241001061264 Astragalus Species 0.000 abstract 1
- 241000132011 Atractylodes lancea Species 0.000 abstract 1
- 240000006432 Carica papaya Species 0.000 abstract 1
- 235000009467 Carica papaya Nutrition 0.000 abstract 1
- 244000020518 Carthamus tinctorius Species 0.000 abstract 1
- 235000003255 Carthamus tinctorius Nutrition 0.000 abstract 1
- 235000001287 Guettarda speciosa Nutrition 0.000 abstract 1
- 244000018716 Impatiens biflora Species 0.000 abstract 1
- 235000015912 Impatiens biflora Nutrition 0.000 abstract 1
- 241000244365 Ligusticum sinense Species 0.000 abstract 1
- 241000195954 Lycopodium clavatum Species 0.000 abstract 1
- 241000951473 Schizonepeta Species 0.000 abstract 1
- 235000005155 Tanacetum balsamita Nutrition 0.000 abstract 1
- 238000010521 absorption reaction Methods 0.000 abstract 1
- 235000006533 astragalus Nutrition 0.000 abstract 1
- 230000007123 defense Effects 0.000 abstract 1
- 230000029142 excretion Effects 0.000 abstract 1
- 230000036039 immunity Effects 0.000 abstract 1
- 238000011084 recovery Methods 0.000 abstract 1
- 210000004233 talus Anatomy 0.000 abstract 1
- 208000024891 symptom Diseases 0.000 description 5
- 210000004556 brain Anatomy 0.000 description 4
- 230000001225 therapeutic effect Effects 0.000 description 4
- 208000002173 dizziness Diseases 0.000 description 3
- 206010003694 Atrophy Diseases 0.000 description 2
- 206010012289 Dementia Diseases 0.000 description 2
- 239000009636 Huang Qi Substances 0.000 description 2
- 206010044565 Tremor Diseases 0.000 description 2
- 206010047513 Vision blurred Diseases 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 230000037444 atrophy Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 208000024827 Alzheimer disease Diseases 0.000 description 1
- 206010006100 Bradykinesia Diseases 0.000 description 1
- 208000006083 Hypokinesia Diseases 0.000 description 1
- 206010027336 Menstruation delayed Diseases 0.000 description 1
- 208000036626 Mental retardation Diseases 0.000 description 1
- 208000021642 Muscular disease Diseases 0.000 description 1
- 201000009623 Myopathy Diseases 0.000 description 1
- 208000028017 Psychotic disease Diseases 0.000 description 1
- 206010039966 Senile dementia Diseases 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- 238000005452 bending Methods 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 230000007177 brain activity Effects 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 239000007919 dispersible tablet Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000008451 emotion Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000003958 fumigation Methods 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- 230000003950 pathogenic mechanism Effects 0.000 description 1
- 208000037920 primary disease Diseases 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 230000024883 vasodilation Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a medicament for treating encephalatrophy. The medicament is prepared from the following crude medicaments in parts by weight: 20 to 50 parts of astragalus, 10 to 30 parts of angelica, 5 to 20 parts of safflower, 10 to 30 parts of papaya, 10 to 40 parts of atractylodes lancea, 10 to 40 parts of angelica dahurica, 10 to 30 parts of cortex acanthopanacis, 10 to 30 parts of schizonepeta, 10 to 30 parts of divaricate saposhnikovia root, 10 to 30 parts of ligusticum chuanxiong, 5 to 20 parts of incised notopterygium rhizome, 10 to 30 parts of common clubmoss herb and 10 to 30 parts of garden balsam stem. According to the medicament for treating the encephalatrophy, the blood vessels of a patient are dilated by the thermal radiation effect of the medicament, so that the blood circulation is improved. When the medicament acts on organisms after being fumigated, the volatile components of the medicament are absorbed by skin, higher concentration can be locally maintained, and the medicament can work for long time, and has the positive effects of improving the permeability and blood circulation of the blood vessels, accelerating the excretion of metabolites, promoting the absorption of inflammatory painful factors, improving the defense capability and immunity of the organisms and promoting functional recovery.
Description
Technical field
The present invention relates to tcm field, relate in particular to a kind of medicament for the treatment of brain atrophy.
Background technology
Brain atrophy refers to owing to a variety of causes causes cerebral tissue itself the neural psychotic disorder of a class that organic disease produces atrophy take place.Brain atrophy comprises children's's brain atrophy, Adult Human Brain atrophy.See with the old people more.Atrophy is dull-witted in clinical topmost symptom, especially old people Yi Yinqi senile dementia.Brain atrophy belongs to categories such as the traditional Chinese medical science " dementia ", " forgetful ", " dizzy ", " myopathy ", " trembling ".Though the traditional Chinese medical science is thought the sick position of primary disease at brain, closely related with each function, pathomechanism belongs to deficiency in origin and excess in superficiality.
Summary of the invention
The purpose of this invention is to provide a kind of medicament for the treatment of brain atrophy.
In order to realize purpose of the present invention, the invention provides a kind of medicament for the treatment of brain atrophy, it is to be made by weight by following bulk drugs: Radix Astragali 20-50 part, Radix Angelicae Sinensis 10-30 part, Flos Carthami 5-20 part, Fructus Chaenomelis 10-30 part, Rhizoma Atractylodis 10-40 part, Radix Angelicae Dahuricae 10-40 part, Cortex Acanthopancis 10-30 part, Herba Schizonepetae 10-30 part, Radix Saposhnikoviae 10-30 part, Rhizoma Chuanxiong 10-30 part, Rhizoma Et Radix Notopterygii 5-20 part, Herba Lycopodii 10-30 part and Herba speranskiae tuberculatae 10-30 part.
Preferably, the medicament for the treatment of brain atrophy of the present invention is to be made by weight by following bulk drugs: 15 parts of 30 parts of the Radixs Astragali, 15 parts of Radix Angelicae Sinensis, 10 parts on Flos Carthami, 20 parts of Fructus Chaenomeliss, 20 parts of Rhizoma Atractylodis, 20 parts of the Radixs Angelicae Dahuricae, 15 parts of Cortex Acanthopanciss, 15 parts of Herba Schizonepetae, 15 parts of Radix Saposhnikoviaes, 20 parts of Rhizoma Chuanxiongs, 15 parts of Rhizoma Et Radix Notopterygiis, 15 parts of Herba Lycopodiis and Herba speranskiae tuberculataes.
Preferably, the medicament for the treatment of brain atrophy of the present invention is tablet, dispersible tablet, fumigant or decoction.
The medicament for the treatment of brain atrophy of the present invention makes affected part vasodilation by the heat radiation effect of medicine, and blood circulation improves.Medicine acts on body after fumigating after, its volatile ingredient absorbs through skin, the part can keep higher concentration, can play a role for a long time, drain, promote inflammatory to cause that the pain factor absorbs, improves body defence and immunocompetence, the promotion functional rehabilitation has positive effect for the permeability that improves blood vessel and blood circulation, quickening metabolite.
The specific embodiment
Below the invention will be further described for the description by the specific embodiment, but this is not to be limitation of the present invention, those skilled in the art are according to basic thought of the present invention, can make various modifications or improvement, but only otherwise break away from basic thought of the present invention, all within the scope of the present invention.
The preparation of embodiment 1 fumigant of the present invention
Get the Radix Astragali 300 grams, Radix Angelicae Sinensis 150 grams, Flos Carthami 100 grams, Fructus Chaenomelis 200 grams, Rhizoma Atractylodis 200 grams, the Radix Angelicae Dahuricae 200 grams, Cortex Acanthopancis 150 grams, Herba Schizonepetae 150 grams, Radix Saposhnikoviae 150 grams, Rhizoma Chuanxiong 200 grams, Rhizoma Et Radix Notopterygii 150 grams, Herba Lycopodii 150 grams and Herba speranskiae tuberculatae 150 grams, pulverize, cross 20 mesh sieves, divide equally in 10 bags.
Experimental example
Diagnostic criteria
Can be summarized as three aspect syndromes according to symptom and sign: (1) spirit changes: have a dull expression on one's face, mental retardation has a lapse of memory, forfeiture study and elaborative faculty, language undercurrent profit, dementia.(2) characteristic changing: as the forfeiture emotion, sometimes centered by the individual.(3) action changes: late period is particularly evident, numb limbs and tense tendons, tremble, as the position of bending over to bend, brothers' activity are ineffective, and easily wrestling, passive action has resistance often, and motion can not continue, and closes one's eyes, lolls or watch certain orientation etc. attentively as not keeping; Diseases such as forgetful, dizzy, tinnitus, blurring of vision.Auxiliary examination: CT shows that the brain material density lowers, and the ventricles of the brain increase, and brain Chi Gou, fissura sylvius, center are split all and enlarged, and the CT value is lower than normal brain activity ditch.
Choose patient's 80 examples that meet above-mentioned standard, male 40 examples, women 40 examples; Age 57-74 year, average 64.5 years old.
The fumigant of preparation among the embodiment 1 is placed the therapeutic bed steam generator for 1 bag, add clean water 4000ml, steam off generator lid is standby.During treatment, start power key during application, decoct 25min again after making Chinese medicine in the therapeutic bed steam generator reach boiling point, with temperature modulation patient preference temperature, allowing the patient lie on the back then treats on the massage lathe in full-computerized multifunctional drug vapour, to treat window and aim at the head dorsal part, start the fumigation treatment key, enter the herb steam therapy state.1 time on the 1st, 30 times was 1 course for the treatment of.Continuous 2 courses for the treatment of.
Criterion of therapeutical effect
Cure: cardinal symptom disappears substantially, and is conscious, and dizzy, blurring of vision disappears, directed sound, and it is correct to answer a question, and takes care of oneself; Effectively: cardinal symptom alleviates to some extent or part disappears, and life is taken care of oneself substantially, but bradykinesia, intelligence and personality seemingly have partial impairment; Invalid: symptom, sign do not have obvious improvement.
After treating 2 courses for the treatment of, all patients all meet the criterion of therapeutical effect of healing, and do not find tangible untoward reaction in the therapeutic process.
Claims (1)
1. fumigant for the treatment of brain atrophy, it is characterized in that it is to be made by weight by following bulk drugs: 15 parts of 30 parts of the Radixs Astragali, 15 parts of Radix Angelicae Sinensis, 10 parts on Flos Carthami, 20 parts of Fructus Chaenomeliss, 20 parts of Rhizoma Atractylodis, 20 parts of the Radixs Angelicae Dahuricae, 15 parts of Cortex Acanthopanciss, 15 parts of Herba Schizonepetae, 15 parts of Radix Saposhnikoviaes, 20 parts of Rhizoma Chuanxiongs, 15 parts of Rhizoma Et Radix Notopterygiis, 15 parts of Herba Lycopodiis and Herba speranskiae tuberculataes.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 201210142857 CN102631436B (en) | 2012-05-10 | 2012-05-10 | Medicament for treating encephalatrophy |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 201210142857 CN102631436B (en) | 2012-05-10 | 2012-05-10 | Medicament for treating encephalatrophy |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102631436A CN102631436A (en) | 2012-08-15 |
| CN102631436B true CN102631436B (en) | 2013-08-21 |
Family
ID=46616115
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 201210142857 Active CN102631436B (en) | 2012-05-10 | 2012-05-10 | Medicament for treating encephalatrophy |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102631436B (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101823892B1 (en) * | 2014-03-10 | 2018-02-01 | 우석대학교 산학협력단 | Impatiens balsamina extracts for the improvement of memory and cognition ability, prevention delay or treatment of Alzheimer's disease, Pharmaceutical composition containing the extracts, Supplementary Food containing the extracts and Method of preparing the extracts |
| CN114344436A (en) * | 2022-01-11 | 2022-04-15 | 徐世芳 | Ginseng and pilose antler tonic wine |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20090083780A (en) * | 2008-01-30 | 2009-08-04 | 주식회사 유비오스랩 | Pharmaceutical composition for the prevention and treatment of dementia, containing ginsenoside-F2 and ginsenoside-CＫ as main components |
| WO2010110755A1 (en) * | 2009-03-27 | 2010-09-30 | Moleac Pte. Ltd. | Therapy for promoting cell growth |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1176687C (en) * | 2002-03-28 | 2004-11-24 | 山西桂龙医药有限公司 | Medicine for strengthning intelligence and delaying senility and its prepn |
| CN100435813C (en) * | 2002-05-20 | 2008-11-26 | 陈建军 | Series medicines for treating headache |
| CN102429956B (en) * | 2011-12-06 | 2013-09-18 | 韩远乐 | External wash and use method thereof |
-
2012
- 2012-05-10 CN CN 201210142857 patent/CN102631436B/en active Active
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20090083780A (en) * | 2008-01-30 | 2009-08-04 | 주식회사 유비오스랩 | Pharmaceutical composition for the prevention and treatment of dementia, containing ginsenoside-F2 and ginsenoside-CＫ as main components |
| WO2010110755A1 (en) * | 2009-03-27 | 2010-09-30 | Moleac Pte. Ltd. | Therapy for promoting cell growth |
Also Published As
| Publication number | Publication date |
|---|---|
| CN102631436A (en) | 2012-08-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102631436B (en) | Medicament for treating encephalatrophy | |
| CN102872301B (en) | Anti-rheumatism medicinal liquor and using method thereof | |
| CN103565969A (en) | Traditional Chinese medicine composition for treating soft tissue injury and fracture | |
| CN103191286B (en) | Traditional Chinese medicine for treating temporomandibular disorders | |
| CN102370942B (en) | Traditional Chinese medicine composition for treating epilepsy | |
| CN106308277A (en) | Medicinal pillow having efficacies for cervical spondylosis and preparation method of medicinal pillow | |
| CN100581571C (en) | Chinese herbal medicine preparations for treating cerebral pasly through immersion | |
| CN104524464A (en) | Traditional Chinese medicine preparation for treating hyperactivity and preparation method of traditional Chinese medicine preparation | |
| CN103893309A (en) | Medicament for treating rheumatoid arthritis | |
| CN103083517A (en) | Traditional Chinese medicine for treating child cerebral palsy | |
| CN102716212B (en) | Medicine for treating cerebral infarction | |
| CN102349957A (en) | Traditional Chinese medicine composition for treating prurigo | |
| CN101474267B (en) | Medicament for treating psychasthenia, insomnia, vexation, encephalatrophy and dementia | |
| CN104666799A (en) | Blood circulation activating and blood stasis removing medicinal liquor for soft tissue injury and preparation method of medicinal liqour | |
| CN104383018A (en) | Lumbar degenerative pathological change treating traditional Chinese medicine composition plaster | |
| CN104435582A (en) | Traditional Chinese medicine plaster for treating depression and insomnia of middle-aged and old people | |
| CN109731047A (en) | It is a kind of to treat disc herniation, osteoproliferation, rheumatism numbness pain, the arthralgia and myalgia cream of neck-shoulder pain, lumbago and leg pain and preparation method | |
| CN102430030A (en) | Traditional Chinese medicine composition for treating bone rheumatism | |
| CN102973882A (en) | Traditional Chinese medicine for treating cervical spondylosis | |
| CN102204966B (en) | Externally-used traditional Chinese medicine liniment for relaxing tendons and relieving pain | |
| CN101843810A (en) | Medicinal liquor for treating bi syndromes and preparation method thereof | |
| CN100384446C (en) | Medicine emplastrum for treating osteoproliferation and its preparing method | |
| CN106310140A (en) | Drug for treating postnatal depression | |
| CN105998738A (en) | Traditional Chinese medicinal composition for treating night sweat | |
| CN105148051A (en) | Traditional Chinese medicinal composition for treating chronic prostatitis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant |